These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Isolating the incentive salience of reward-associated stimuli: value, choice, and persistence. Beckmann JS; Chow JJ Learn Mem; 2015 Feb; 22(2):116-27. PubMed ID: 25593298 [TBL] [Abstract][Full Text] [Related]
48. The sensory features of a food cue influence its ability to act as an incentive stimulus and evoke dopamine release in the nucleus accumbens core. Singer BF; Bryan MA; Popov P; Scarff R; Carter C; Wright E; Aragona BJ; Robinson TE Learn Mem; 2016 Nov; 23(11):595-606. PubMed ID: 27918279 [TBL] [Abstract][Full Text] [Related]
49. Dopamine antagonism does not impair learning of Pavlovian conditioned approach to manipulable or non-manipulable cues but biases responding towards goal tracking. Scülfort SA; Bartsch D; Enkel T Behav Brain Res; 2016 Nov; 314():1-5. PubMed ID: 27478141 [TBL] [Abstract][Full Text] [Related]
50. Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats. Neelakantan H; Holliday ED; Fox RG; Stutz SJ; Comer SD; Haney M; Anastasio NC; Moeller FG; Cunningham KA ACS Chem Neurosci; 2017 May; 8(5):1065-1073. PubMed ID: 28107783 [TBL] [Abstract][Full Text] [Related]
51. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis. Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720 [TBL] [Abstract][Full Text] [Related]
53. Corticosterone urinalysis and nicotinic receptor modulation in rats. Loomis S; Gilmour G J Neurosci Methods; 2010 May; 188(2):243-9. PubMed ID: 20171986 [TBL] [Abstract][Full Text] [Related]
54. The ability for cocaine and cocaine-associated cues to compete for attention. Pitchers KK; Wood TR; Skrzynski CJ; Robinson TE; Sarter M Behav Brain Res; 2017 Mar; 320():302-315. PubMed ID: 27890441 [TBL] [Abstract][Full Text] [Related]
55. Effects of two kinds of noradrenergic ADHD medicines on sign-tracking and goal-tracking in male rats. Holden JM Exp Clin Psychopharmacol; 2022 Dec; 30(6):760-773. PubMed ID: 34968108 [TBL] [Abstract][Full Text] [Related]
56. Toward isolating the role of dopamine in the acquisition of incentive salience attribution. Chow JJ; Nickell JR; Darna M; Beckmann JS Neuropharmacology; 2016 Oct; 109():320-331. PubMed ID: 27371135 [TBL] [Abstract][Full Text] [Related]
57. Sign-tracking behavior is difficult to extinguish and resistant to multiple cognitive enhancers. Fitzpatrick CJ; Geary T; Creeden JF; Morrow JD Neurobiol Learn Mem; 2019 Sep; 163():107045. PubMed ID: 31319166 [TBL] [Abstract][Full Text] [Related]